Vernal Biosciences

Private

Colchester, VermontHealthcare & Life Scienceshttps://www.vernal.bio/

Last Round

Series A

Extension

Jun 15, 2023

Total Funding Raised

$20M

Company Overview

Vernal Biosciences is a biotechnology company that provides high-purity mRNA and LNP-mRNA manufacturing services for research and clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CDMOmRNA manufacturinglipid nanoparticleLNPGMP manufacturingbiotech manufacturingcontract manufacturingmRNA therapeuticsprocess developmentanalytical developmentbiotech supply chaindrug developmentclinical supplybioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vernal Biosciences Comps

Public and private peers based on sector, stage, and business model.

Vernal Biosciences comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vernal Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Jun 15, 2023
VC Round	Jun 2, 2022
Seed	Jul 12, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Christian Cobaugh

Chief Scientific Officer And Founder

Founding Team

Vernal Biosciences Investors

Notable investors and investment history

Vernal Biosciences investors
Investor	Rounds
Dynamk Capital	Series A Extension, VC Round
Ampersand Capital	VC Round, Series A Extension
Vermont Center for Emerging Technologies	Seed, Series A Extension

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 27, 2023
$20M round led by Ampersand Capital and Charles River Laboratories

View all signals

Vernal Biosciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Vernal Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vernal Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersColchester, Vermont

Employee Range11

Year Founded2021

Last FundingJun 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.